Ghiulser Selim
Family Medicine · East Lansing, MINPI 1245203645
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 8.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $955 and has fallen 84.5% since, to $148 in 2023.
Across 116 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$172
- AbbVie$150
- Alkermes, Inc.$140
- Sanofi-aventis U.S. LLC$129
- Vanda Pharmaceuticals Inc.$113
- Bayer$112
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,016100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 8 | $172 |
| AbbVie(2 entities) | 10 | $150 |
| Alkermes, Inc. | 6 | $140 |
| Sanofi-aventis U.S. LLC | 7 | $129 |
| Vanda Pharmaceuticals Inc. | 4 | $113 |
| Bayer | 6 | $112 |
| Novo Nordisk | 7 | $100 |
| GSK | 7 | $96 |
| Ironshore Pharmaceuticals Inc. | 5 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $83 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $81 |
| Pfizer | 4 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $65 |
| Amgen | 4 | $60 |
| Neurocrine Biosciences, Inc. | 3 | $59 |
| Boehringer Ingelheim | 3 | $55 |
| Amarin Pharma, Inc. | 3 | $43 |
| Astellas Pharma US Inc | 2 | $37 |
| Abbott | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 3 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| AstraZeneca(2 entities) | 2 | $33 |
| Lilly USA, LLC | 2 | $30 |
| Phadia US Inc. | 2 | $25 |
| Mylan Specialty L.p. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
| Brainsway USA Inc | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$2,016 in reported general payments places this provider in the 80th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in East Lansing
- Kim PfotenhauerEast Lansing$61K
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- James VoigtOak Park$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.